PharmaCielo Ltd.
PCLO.V
TSX
| 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | 09/30/2023 | |
|---|---|---|---|---|---|
| Net Income | -1.94M | -1.88M | -1.80M | -4.70M | -2.06M |
| Total Depreciation and Amortization | -20.60K | 37.00K | 69.50K | 43.50K | 268.00K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 1.56M | 1.59M | 644.90K | 2.85M | 956.70K |
| Change in Net Operating Assets | -5.30K | -183.10K | 768.90K | 577.60K | 152.50K |
| Cash from Operations | -405.10K | -442.10K | -311.80K | -1.23M | -680.90K |
| Capital Expenditure | -- | -- | -- | -3.90K | -400.00 |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 0.00 | 0.00 | 30.50K | 167.50K | 43.20K |
| Cash from Investing | 0.00 | 0.00 | 30.50K | 163.60K | 42.80K |
| Total Debt Issued | 0.00 | 670.00K | 315.00K | 1.82M | 850.00K |
| Total Debt Repaid | -68.20K | -386.00K | -61.40K | -340.80K | -74.50K |
| Issuance of Common Stock | 607.00K | 425.00K | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -237.00K | 237.00K | -- | -- |
| Cash from Financing | 395.10K | 345.00K | 363.90K | 1.08M | 578.10K |
| Foreign Exchange rate Adjustments | -500.00 | -3.30K | 2.70K | 8.60K | -600.00 |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -10.50K | -100.50K | 85.30K | 27.90K | -60.60K |
